Cutaneous malignant melanoma is one of the most common and deadliest cancers, and its incidence continues to rise to epidemic proportions, to the extent that it is now the most prevalent cancer among women under forty. The solar ultraviolet radiation (UV) is widely accepted to be the greatest risk factor for melanoma; however, the underlying molecular mechanisms are incompletely understood. Identification of the causal UV-induced mutations has long been the major thrust in the field, but importance of non-mutational and microenvironmental mechanisms, for example inflammation and immunoevasion/immunosuppression, remains severely understudied. Here we have proposed a hypothesis that Interferon-gamma (IFNg), which is conventionally associated with anti-tumor immunesurveillance mechanisms, plays a pro-tumorigenic role in the context of UV-induced melanomagenesis. The proposed research will elucidate the mechanisms of the pro-melanomagenic effects of IFNg.
In Specific Aim 1, the specific mechanisms of the pro-metastatic and drug resistance effects of IFNg treatment on melanoma cells via activation of Signal Transducer and Activator of Transcription 3 (STAT3) and Microphthalmia Associated Transcription Factor (MITF) will be tested. UV- induced melanomagenesis experiments will be performed in the inducible BrafV600E (BrafCA)mouse model of UV-induced melanomagenesis, in which the IFNg signaling has been blocked via melanocyte-specific knockout of IFNg-Receptor.
Specific Aim 2 will characterize the IFNg-secreting (IFNg+) macrophages that are recruited to the skin microenvironment by erythemal UV exposure, and will validate this novel subpopulation of macrophages as a biomarker of susceptibility and prognosis of human melanoma. It will be determined whether genetic blockade of UV-induced macrophage influx into skin inhibits melanomagenesis.
In Specific Aim 3, the role of IFNg-induced expression of the cytotoxic T-lymphocyte antigen 4 (CTLA4) in melanoma cells in the process of melanomagenesis will be investigated. It will be tested whether melanocytic expression of CTLA4 protects them from T-cell-mediated immunesurveillance, leading to immunoevasion and progression of melanoma, and whether genetic ablation of Ctla4 specifically in the melanocyte compartment inhibits UV-induced melanomagenesis in the BrafCA mouse model. Finally, CTLA4 expression on melanoma cells will be investigated as a predictive biomarker of response to anti-CTLA4 immunotherapy in clinical samples of human melanoma patients. The overall goal of the proposed project is to investigate the IFNg pathway as a novel microenvironmental mechanistic link to UV-induced melanoma susceptibility and disease progression.
Melanoma is the deadliest form of skin cancer that continues to rise to epidemic proportions in the United States. Although it is accepted that exposure to the ultraviolet (UV) radiation from sun is the single greatest risk factor for melanoma, the underlying molecular mechanisms of this cause-and-effect relationship remain unclear. The studies proposed in this application will potentially delineate the causes of UV-induced melanoma at the molecular and cellular level, which will aid identification of novel strategies for the treatment ad prevention of melanoma. Furthermore, these studies will identify potential biomarkers for melanoma susceptibility and clinical response to immunotherapy, which will be useful for personalized management of melanoma patients in the clinic.
| Preston, Sarah; Aras, Shweta; Zaidi, M Raza (2018) Spatiotemporal Labeling of Melanocytes in Mice. Int J Mol Sci 19: |
| Soboloff, Jonathan; Gligorijevic, Bojana; Zaidi, M Raza (2018) STIM1 (c)AMPs up melanogenesis. EMBO J 37: |
| Zaidi, M Raza (2018) The Interferon-Gamma Paradox in Cancer. J Interferon Cytokine Res : |
| Mo, Xuan; Zhang, Hanghang; Preston, Sarah et al. (2018) Interferon-? Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4. Cancer Res 78:436-450 |
| Aras, Shweta; Zaidi, M Raza (2017) TAMeless traitors: macrophages in cancer progression and metastasis. Br J Cancer 117:1583-1591 |
| Pérez-Guijarro, Eva; Day, Chi-Ping; Merlino, Glenn et al. (2017) Genetically engineered mouse models of melanoma. Cancer 123:2089-2103 |
| Hooper, Robert; Zaidi, M Raza; Soboloff, Jonathan (2016) The heterogeneity of store-operated calcium entry in melanoma. Sci China Life Sci 59:764-9 |
| Mochizuki, Kazuhiro; Meng, Lijun; Mochizuki, Izumi et al. (2016) Programming of donor T cells using allogeneic ?-like ligand 4-positive dendritic cells to reduce GVHD in mice. Blood 127:3270-80 |
